Shanghai Medicilon Inc. (SHA:688202)
China · Delayed Price · Currency is CNY 62.97
-0.48 (-0.76%)
At close: Jan 22, 2026
Shanghai Medicilon Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -231.86 | -330.85 | -33.21 | 338.24 | 282.22 | 129.39 | Upgrade |
Depreciation & Amortization | 109.65 | 109.65 | 103.66 | 79.22 | 58.5 | 28.6 | Upgrade |
Other Amortization | 55.41 | 55.41 | 38.62 | 25.65 | 18.04 | 15.35 | Upgrade |
Loss (Gain) From Sale of Assets | 1.12 | 1.12 | 0.34 | 0.87 | 1.04 | 1.34 | Upgrade |
Asset Writedown & Restructuring Costs | 18.42 | 18.42 | - | 1.64 | 0.84 | 1.01 | Upgrade |
Loss (Gain) From Sale of Investments | -7.02 | -7.02 | -6.33 | -2.46 | - | -0.63 | Upgrade |
Provision & Write-off of Bad Debts | 110.45 | 110.45 | 44.07 | 21.86 | 7.68 | 4.08 | Upgrade |
Other Operating Activities | 42.42 | 30.18 | 27.26 | -3.65 | 5.89 | 9.91 | Upgrade |
Change in Accounts Receivable | -17.22 | -17.22 | -60.36 | -434.33 | -104.96 | 57.76 | Upgrade |
Change in Inventory | 45.21 | 45.21 | -11.69 | -87.64 | -50.79 | -20.87 | Upgrade |
Change in Accounts Payable | 10.05 | 10.05 | -45.19 | 8.11 | 203.04 | -24.27 | Upgrade |
Change in Other Net Operating Assets | 1.96 | 1.96 | 2.76 | 15.59 | 19.28 | 0.14 | Upgrade |
Operating Cash Flow | 88.48 | -22.75 | 33.32 | -21.33 | 452.94 | 207.77 | Upgrade |
Operating Cash Flow Growth | - | - | - | - | 118.00% | 256.39% | Upgrade |
Capital Expenditures | -68.29 | -110.39 | -185.68 | -404.06 | -292.71 | -118.72 | Upgrade |
Sale of Property, Plant & Equipment | 0.01 | 0.01 | 0.27 | - | 0.16 | 0.04 | Upgrade |
Cash Acquisitions | - | - | - | - | -7 | -324.52 | Upgrade |
Investment in Securities | -25.14 | 23.27 | -604.65 | 90 | -100 | 70.89 | Upgrade |
Other Investing Activities | -0.79 | -2.86 | 2.52 | 2.44 | - | 0.71 | Upgrade |
Investing Cash Flow | -94.22 | -89.97 | -787.55 | -311.62 | -399.55 | -371.6 | Upgrade |
Short-Term Debt Issued | - | - | - | 279 | - | - | Upgrade |
Long-Term Debt Issued | - | 320 | 457.1 | - | - | - | Upgrade |
Total Debt Issued | 441.28 | 320 | 457.1 | 279 | - | - | Upgrade |
Short-Term Debt Repaid | - | - | - | -50 | - | - | Upgrade |
Long-Term Debt Repaid | - | -379.48 | -357.74 | -20.19 | -13.9 | - | Upgrade |
Total Debt Repaid | -400.2 | -379.48 | -357.74 | -70.19 | -13.9 | - | Upgrade |
Net Debt Issued (Repaid) | 41.08 | -59.48 | 99.37 | 208.81 | -13.9 | - | Upgrade |
Issuance of Common Stock | 22.07 | - | 1,007 | 6.51 | 6.99 | - | Upgrade |
Repurchase of Common Stock | -40 | -40 | -19.99 | - | - | - | Upgrade |
Common Dividends Paid | -7.59 | -6.97 | -42.14 | -87.33 | -39.06 | - | Upgrade |
Other Financing Activities | -18.41 | -0.26 | -14.45 | -19.06 | -60 | -1.9 | Upgrade |
Financing Cash Flow | -2.84 | -106.71 | 1,030 | 108.94 | -105.97 | -1.9 | Upgrade |
Foreign Exchange Rate Adjustments | 3.41 | 6.13 | -0.19 | 8.17 | -0.99 | -5.11 | Upgrade |
Net Cash Flow | -5.16 | -213.3 | 275.34 | -215.84 | -53.58 | -170.84 | Upgrade |
Free Cash Flow | 20.19 | -133.14 | -152.36 | -425.39 | 160.22 | 89.05 | Upgrade |
Free Cash Flow Growth | - | - | - | - | 79.93% | - | Upgrade |
Free Cash Flow Margin | 1.87% | -12.83% | -11.16% | -25.64% | 13.73% | 13.37% | Upgrade |
Free Cash Flow Per Share | 0.15 | -0.99 | -1.19 | -3.50 | 1.32 | 0.73 | Upgrade |
Cash Income Tax Paid | - | -30.13 | -55.21 | 28.71 | -8.88 | -1.33 | Upgrade |
Levered Free Cash Flow | 85.58 | -78.05 | -159.98 | -583.36 | 14.51 | 21.43 | Upgrade |
Unlevered Free Cash Flow | 91.53 | -72.83 | -153.94 | -580.3 | 15.77 | 21.43 | Upgrade |
Change in Working Capital | -10.12 | -10.12 | -141.09 | -482.72 | 78.72 | 18.72 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.